Original Query: ALL
Previous Study | Return to List | Next Study

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00437424
Recruitment Status : Completed
First Posted : February 21, 2007
Last Update Posted : May 4, 2011
Information provided by:
Bristol-Myers Squibb